BIOPIXLAR®
Fluicell has developed Biopixlar, a game-changing bioprinting platform capable of producing tissue models by printing at the level…
CUSTOMER KEEPS PUSHING THE BOUND OF SCIENCE
Professor Gözen’s Group from the University of Oslo, Norway, has published a nice article entitled “Molecular Lipid Films…
06
Aug
2019
Fluicell appoints Scientific Advisory Board
We hereby announce that the company has appointed a Scientific Advisory Board. The Scientific Advisory Board consists of…
18
Jul
2019
CUSTOMER KEEPS PUSHING THE BOUND OF SCIENCE
Professor Gözen’s Group from the University of Oslo, Norway, has published a significant article entitled “A Nanotube-Mediated Path…
15
Jul
2019
WE SOLD A BIOPEN SYSTEM TO UNIVERSITY OF CAMBRIDGE
We have sold a BioPen® Prime System to University of Cambridge in UK. The BioPen® System enables researchers to…
19
Jun
2019
Welcome to new Fluicell place at Mölndal!
We are extremely happy to announce that we have just moved to bigger premises located in Mölndal. This…
06
May
2019
STERILE BIOPEN PIPETTE TIPS ARE AVAILABLE
We are pleased to announce that sterile BioPen PRIME and FLEX pipette tips are now available. From conception…
10
Apr
2019
We sold a BioPen System to Rockefeller University
We have sold a BioPen® Prime System to Rockefeller University, NYC, USA. The BioPen® System enables researchers to…
02
Apr
2019
First beta testing agreement for Biopixlar with Cellectricon
Fluicell AB today announces that the company has entered into an agreement with Cellectricon AB for beta testing…
28
Mar
2019